scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0969-8051(97)00187-X |
P698 | PubMed publication ID | 9620624 |
P2093 | author name string | Kobayashi K | |
Suzuki K | |||
Inoue O | |||
Haradahira T | |||
P2860 | cites work | Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists | Q69843588 |
High affinity binding of cholecystokinin to small cell lung cancer cells | Q70176866 | ||
Development of 1,4-benzodiazepine cholecystokinin type B antagonists | Q72696583 | ||
Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260. | Q34273972 | ||
The structure of neuropeptide receptors | Q35235165 | ||
Coexistence of neuropeptides and "classical" neurotransmitters. Functional interactions between galanin and acetylcholine | Q36573433 | ||
Cholecystokinin-dopamine interactions | Q37756133 | ||
Cholecystokinin and gastrointestinal cancer | Q38031478 | ||
Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors | Q40624974 | ||
Biological actions of cholecystokinin | Q40638002 | ||
Inhibitory effects of the gastrin receptor antagonist (L-365,260) on gastrointestinal tumor cells | Q42471834 | ||
Autoradiographical detection of cholecystokinin-A receptors in primate brain using 125I-Bolton Hunter CCK-8 and 3H-MK-329. | Q42484339 | ||
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity. 1. Optimization of the agonist "trigger". | Q42557574 | ||
Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365,260. | Q46782752 | ||
Computer-controlled large scale production of high specific activity [11C]RO 15-1788 for PET studies of benzodiazepine receptors | Q48433536 | ||
Imaging dopamine receptors in the human brain by positron tomography | Q48737544 | ||
Dopamine visualized in the basal ganglia of living man. | Q48738961 | ||
Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection | Q51116341 | ||
Evidence for coexistence of dopamine and CCK in meso-limbic neurones | Q59099123 | ||
A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260 | Q69610906 | ||
P433 | issue | 3 | |
P921 | main subject | cholecystokinin | Q60315441 |
P304 | page(s) | 203-208 | |
P577 | publication date | 1998-04-01 | |
P1433 | published in | Nuclear Medicine and Biology | Q7067979 |
P1476 | title | Synthesis and evaluation of 11C-labeled nonpeptide antagonists for cholecystokinin receptors: [11C]L-365,260 and [11C]L-365,346. | |
P478 | volume | 25 |
Q74662965 | An improved synthesis of [11C]L-703,717 as a radioligand for the glycine site of the NMDA receptor |
Q35092695 | Radiolabeling approaches for cholecystokinin B receptor imaging |
Q37152806 | Synthesis and in vitro characterization of radioiodinatable benzodiazepines selective for type 1 and type 2 cholecystokinin receptors |
Q44257027 | Synthesis of no-carrier-added C-11 labeled D- and L-enantiomers of phenylalanine and tyrosine for comparative PET Studies |
Search more.